Home/Pipeline/Biosimilar Candidate

Biosimilar Candidate

Autoimmune Disorders

Pre‑clinicalActive

Key Facts

Indication

Autoimmune Disorders

Phase

Pre‑clinical

Status

Active

Company

Indian pharma firm delivering affordable small‑molecule APIs, generics, and contract manufacturing services worldwide.

Drug	Company	Phase	Status
TNB-512	Tenacia Biotechnology	Phase 1	Active
TYK2 Pseudokinase Inhibitor	A2A Pharma	Preclinical	Preclinical Development
Marine Membrane Lipid Extract(s)	Arctic Bioscience	Pre-clinical	Research & Development
Validated immunology target program	Genesis Therapeutics	Discovery	Active
NAMPT - Autoimmune	Remedy Plan Therapeutics	Discovery	Active
LZB-201	Lazuline Biotech	Preclinical	Active
Autoimmunity Diagnostics	Eurobio	Commercial	Active